The COVID-19 Pandemic and the Migrant Population for HIV Diagnosis and Care Follow-Up: They Are Left Behind.

COVID-19 HIV left behind loss to follow-up migrant people

Journal

Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525

Informations de publication

Date de publication:
24 Aug 2022
Historique:
received: 04 07 2022
revised: 20 08 2022
accepted: 21 08 2022
entrez: 23 9 2022
pubmed: 24 9 2022
medline: 24 9 2022
Statut: epublish

Résumé

The coronavirus 2019 (COVID-19) pandemic has posed numerous worldwide challenges. The level of social vulnerability of the migrant population is disproportionately higher than other populations. Recent reports have shown that the access to care for the migrant population (i.e., non-French nationality patients) were greatly impacted during this pandemic. Thus, we would like to highlight the significant impact of the COVID-19 pandemic on care follow-up in those migrant people infected with HIV who receive HIV care in France. Two groups of patients were defined: that is, patients with continuous care and patients with a loss of follow-up of at least one year during the COVID-19 pandemic. Among 672 HIV patients, 19 (2.7%) patients were lost to follow-up for at least one year during the COVID-19 pandemic. We found no significant difference for gender (p = 0.332) or age (p = 0.115) between the two groups. However, patients with a loss of follow-up were mainly migrants rather than from the other group (p < 0.001), and the same results were observed for the nation of birth (89.5% vs. 44%, p < 0.001). In our hospital, most of the patients who were living abroad but had HIV care in France before the COVID epidemic (mainly retired migrants) were lost to follow-up during the COVID-19 pandemic. To date, most of them have not resumed HIV care in France and we do not know their present situation. We can only observe that the COVID-19 pandemic has predominately disrupted the HIV care of migrant populations. Do not let them be left behind!

Identifiants

pubmed: 36141219
pii: healthcare10091607
doi: 10.3390/healthcare10091607
pmc: PMC9498780
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Glob Health. 2020 Dec;10(2):020342
pubmed: 33110542
EClinicalMedicine. 2021 Jul 01;37:100958
pubmed: 34258570
BMC Public Health. 2022 Jan 20;22(1):143
pubmed: 35057781
PLoS One. 2017 Dec 21;12(12):e0188751
pubmed: 29267347
Clin Infect Dis. 2022 Feb 11;74(3):521-524
pubmed: 33993276
Public Health. 2022 Jun;207:e1-e2
pubmed: 35469659
Life (Basel). 2022 Jul 07;12(7):
pubmed: 35888096
Front Public Health. 2022 Jan 26;10:818989
pubmed: 35155328
Clin Microbiol Infect. 2022 Sep;28(9):1306
pubmed: 35461999
Eur J Public Health. 2011 Oct;21(5):620-6
pubmed: 21051469
Eur J Public Health. 2022 Aug 1;32(4):655-663
pubmed: 35478253
Vaccines (Basel). 2021 Mar 24;9(4):
pubmed: 33804808
Lancet. 2020 Apr 4;395(10230):1089
pubmed: 32247378
J Travel Med. 2017 Jul 1;24(4):
pubmed: 28426114
J Migr Health. 2021 Jun 23;4:100053
pubmed: 34405196

Auteurs

David Zucman (D)

Department of Internal Medicine, Reseau Ville Hôpital Val de Seine, Foch Hospital, 92150 Suresnes, France.

Amina Rasnaama (A)

Department of Internal Medicine, Reseau Ville Hôpital Val de Seine, Foch Hospital, 92150 Suresnes, France.

Catherine Majerholc (C)

Department of Internal Medicine, Reseau Ville Hôpital Val de Seine, Foch Hospital, 92150 Suresnes, France.

Alexandre Vallée (A)

Department of Epidemiology-Data-Biostatistics, Delegation of Clinical Research and Innovation (DRCI), Foch Hospital, 92150 Suresnes, France.

Classifications MeSH